General InformationGero is an AI-driven biotech company based in California, founded in 2019, with 11-50 employees focused on applying machine learning to aging biology research.
Funding & FinancialsThe company has raised approximately $5-8 million in seed and Series A funding, with backing from notable biotech and longevity-focused investors.
Leadership & TeamCEO and co-founder Peter Fedichev is a physicist and computational biologist with expertise in aging research and machine learning applications to biology.
Recent ActivityGero has been advancing its AI platform for identifying aging-related drug targets and collaborating with research institutions on longevity biomarker discovery and validation.